Improving the power for detecting overlapping genes from multiple DNA microarray-derived gene lists by Deng, Xutao et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Bioinformatics
Open Access Research
Improving the power for detecting overlapping genes from multiple 
DNA microarray-derived gene lists
Xutao Deng1,2, Jun Xu1 and Charles Wang*1,2
Address: 1Transcriptional Genomics Core, Burns Allen Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA and 2Department of 
Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, USA
Email: Xutao Deng - dengx@ucla.edu; Jun Xu - xuj@cshs.org; Charles Wang* - charles.wang@cshs.org
* Corresponding author    
Abstract
Background: In DNA microarray gene expression profiling studies, a fundamental task is to
extract statistically significant genes that meet certain research hypothesis. Currently, Venn
diagram is a frequently used method for identifying overlapping genes that meet the investigator's
research hypotheses. However this simple operation of intersecting multiple gene lists, known as
the Intersection-Union Tests (IUTs), is performed without knowing the incurred changes in Type
1 error rate and can lead to loss of discovery power.
Results: We developed an IUT adjustment procedure, called Relaxed IUT (RIUT), which is proved
to be less conservative and more powerful for intersecting independent tests than the traditional
Venn diagram approach. The advantage of the RIUT procedure over traditional IUT is
demonstrated by empirical Monte-Carlo simulation and two real toxicogenomic gene expression
case studies. Notably, the enhanced power of RIUT enables it to identify overlapping gene sets
leading to identification of certain known related pathways which were not detected using the
traditional IUT method.
Conclusion: We showed that traditional IUT via a Venn diagram is generally conservative, which
may lead to loss discovery power in DNA microarray studies. RIUT is proved to be a more
powerful alternative for performing IUTs in identifying overlapping genes from multiple gene lists
derived from microarray gene expression profiling.
Background
Nowadays many microarray-based studies adopt complex
experimental design involving multiple treatments, cell
lines/tissues, multiple dosages, time points, phenotypes
and so on [1-4]. These studies are often involved with
complex research hypotheses. For instance in one of our
previous studies [1], we were interested in identifying dif-
ferentially expressed genes (DEGs) in responding to com-
mon bile duct ligation in bone marrow stem cells
(BMSCs) compared against primary hepatocytes. Two
DEG sets from BMSCs and hepatocytes were identified
respectively, and the overlapping genes across the two cell
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types were obtained. The overlapping genes produced
across the two cell types allowed the identification of
common biological pathways, ontological classes, and
biological mechanisms across the two cell types in
responding to the treatment.
The intersection operations on multiple gene lists are
equivalent to performing multiple tests for the combined
hypotheses on every single gene. Although there are many
statistical tests proposed for gene expression studies [5-8],
the problems of obtaining overlapping gene sets based on
multiple tests were overlooked in microarray-based stud-
ies. To obtain genes that satisfy the specific hypotheses,
researchers simply overlap the gene sets from multiple
gene sets and visualized them in Venn diagrams. How-
ever, because of lacking multiplicity adjustment, this pro-
cedure overlooks the changes of statistical properties, i.e.,
power, type 1 error rate, p-values, during the intersection
operations. This type of multiple testing for finding over-
lapping genes is known as the Intersection-Union Test
(IUT). Despite some early efforts [9-11], the statistical
properties and adjustment algorithms of IUT are not well
established. Berger has proved that IUT without multiplic-
ity adjustment is a level-α test [10], when the individual
tests were controlled at type 1 error rate α. However, the
family wise error rate (FWER) for IUT α' is generally much
smaller than α. Therefore, performing IUT without multi-
plicity adjustment would be very conservative and result
in too many false negatives.
In this paper, we show that current overlapping operation,
applying no p-value adjustment for IUT, is overly conserv-
ative in general. As a result, current microarray studies suf-
fer from low power in detecting overlapping genes and
therefore limit its use in biological data mining. We devel-
oped an analytical solution, named as Relaxed IUT (RIUT)
for the multiplicity adjustment of IUTs under certain con-
ditions. We theoretically proved that our proposed
method is a less conservative and more powerful than cur-
rent approaches. We demonstrated the superiority of
RIUT for detecting overlapping genes in simulated data
sets and complex microarray-based toxicogenomic stud-
ies.
Results
Monte-Carlo simulation results of RIUT
As an example to showcase the power of RIUT, the mRNA
expression of a given gene is tested whether it is signifi-
cantly altered by a drug treatment in multiple tissues. Sup-
pose gene expressions were measured in m  different
tissues and one is interested in the overlapping DEGs. For
each tissue, a two-sample t-test is performed between a
treatment group and a control group, each containing n
replicates to obtain a list of significant genes for that tis-
sue. Then we have an IUT that is constructed by m individ-
ual tests, each for a different tissue:
H0i: the drug has no effect in the ith tissue, i.e., μti = μci,
HAi: the drug has effect in the ith tissue, i.e., μti ≠ μci, 1 ≤ i
≤ m,
where μti and μci denote the expression mean of the treat-
ment and the control groups respectively of the ith tissue.
The hypotheses for IUT are H0: the drug shows no effect
on at least one tissue vs. HA: the drug shows effect on all
tissues.
For the Monte-Carlo simulation, the expression data for
the treatment and control groups were modeled as normal
distributions N(μti, 1) and N(μci, 1) respectively, where μci
= 0, 1 ≤ i ≤ m. We then drew n = 5 samples from each of
these distributions and apply RIUT and BIUT to these sim-
ulated data. Table 1 shows the estimated type 1 error rate
by 10000 simulated instances of IUT formed by 2 individ-
ual tests. Expression mean μt1 is fixed at 0 for the first tis-
sue and different values of μt2 were used to represent the
drug having diverse effects (μt2 = 0, 0.5, ..., 4.5, 5.0) on the
second tissue. Overall, the drug has no effect on the first
tissue and the null hypothesis H0 of IUT is true. Results
show that both RIUT and traditional Berger's IUT (BIUT)
are bounded by nominal α at which the individual
hypotheses were tested. The actual type 1 error for IUT is
generally smaller than α. RIUT is less conservative than
BIUT as it achieves a type 1 error rate that is closer to α. To
prove concept, we also tested two meta-analysis methods
for combining independent tests, the Fisher's method
[15] and Stouffer's method [16]. The results show that
their actual type 1 rate can be so much higher than the
nominal one that these methods are not suitable for the
IUTs.
At μt1= μt2 = 0, the resultant p-value distributions gener-
ated from 10000 instances were illustrated in Figure 1.
Theoretically, the p-values originated from null hypothe-
sis should appear approximately uniformly distributed
(the dashed line). The adjusted p' using RIUT achieved the
desired distribution as shown in Figure 1a. However, Fig-
ure 1b shows that the unadjusted p is seriously skewed to
the right, indicating that the test is overly conservative.
Table 2 shows the power estimate of IUT consisting of two
individual tests and both individual null hypotheses are
not true (μt1 = 0.5, μt2 = 0, 0.5, ..., 4.5, 5.0). RIUT demon-
strated higher power than BIUT at small and moderate
effect size. At large effect size, RIUT and BIUT show essen-
tially the same power.BMC Bioinformatics 2008, 9(Suppl 6):S14 http://www.biomedcentral.com/1471-2105/9/S6/S14
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As a more realistic simulation, we pooled instances being
positive (H0 not true) and negative (H0 true). We use γ to
denote the simulation Bernoulli probability that an indi-
vidual hypothesis is not null such that Prob(HAi) = γ. The
population means were set at μt1 = μt2 = 0.5. According to
this procedure, we simulated 10000 instances under dif-
ferent γ and the resultant number of true negative and true
positive were denoted as K0 and K1 respectively. The iden-
tified false positive and true positives were notated as V
and S respectively. The results in Table 3 confirmed our
previous observations that RIUT is a more powerful and
less conservative. The same patterns were observed in sim-
ulations using other parameter values (results not
shown).
Identifying overlapping genes that respond to multiple 
drug treatment
This example illustrates how RIUT algorithm can be used
in real DNA microarray-based multiple-testing problems.
Originally generated from the MAQC project [2], this data
set consists of rat RNA samples that came from six treat-
ment/tissue groups. The treatment/tissue groups were
aristolochic acid/liver, aristolochic acid/kidney, riddelli-
ine/liver, comfrey/liver, control/liver and control/kidney.
There were six biological replicates in each treatment/tis-
sue group. mRNA expression profiles were obtained using
four commercial platforms including Affymetrix (Rat
Genome 230 2.0), Agilent (Whole Rat Genome Oligo
Microarray, G4131A), Applied Biosystems (Rat Genome
Survey Microarray) and GE Healthcare (RatWhole
Genome Bioarray, 300031) in five different labs with two
labs using the Affymetrix microarray platform. Totally,
180 chips were obtained and the cross-platform probe-
mapping gave rise to 4609 genes commonly detected
across four platforms.
In this example, our goal is to identify the common genes
responding to different drug treatments. These genes may
shed lights on common cytotoxicity mechanisms of these
drugs. We used the liver/control (L_CTL) group as control
and the 3 drugs treatment at rat liver were referred to as
L_AA, L_CFY, and L_RDL respectively. The IUT consists of
two individual tests, (i.e., t1: L_AA vs. L_CTL and t2: L_CFY
vs. L_CTL), each testing whether a gene differentially
expressed in response to one specific drug treatment ver-
sus control. The combined IUT was used to identify the
genes that differentially expressed in combined each pair
of the three treatments. Table 4 shows the number of over-
lapping differentially expressed genes identified using
RIUT compared with the traditional BIUT at different
labs/platforms. As expected, the number of significant
genes obtained using RIUT is consistently greater than
that obtained using BIUT. The magnitude of increase
ranges from 13% to 184%. For many IUTs, the number of
Distributions of the p-values of 10000 simulations with μt1 =  μt2 = 0.0 using RIUT and BIUT Figure 1
Distributions of the p-values of 10000 simulations 
with μt1 = μt2 = 0.0 using RIUT and BIUT. a. The distri-
bution of RIUT p-value p'. b. The distribution of unadjusted 
BIUT p-value p. The dashed line indicates the hypothetical 
uniform distribution of the p-values of the 10000 runs.
Table 1: Monte-Carlo estimates of type 1 error rate α'(%)
μt2 RIUT BIUT Fisher Stouffer
0.0 0.047 0.003 0.050 0.050
0.5 0.044 0.006 0.090 0.085
1.0 0.035 0.015 0.210 0.188
1.5 0.035 0.027 0.405 0.327
2.0 0.040 0.039 0.632 0.476
2.5 0.049 0.048 0.821 0.621
3.0 0.048 0.048 0.931 0.729
3.5 0.047 0.047 0.982 0.808
4.0 0.051 0.051 0.995 0.875
4.5 0.048 0.048 0.999 0.907
5.0 0.046 0.046 1.000 0.930
m = 2, n = 5, and μt1 = 0.0; individual tests were performed at α = 
0.05 and each estimate were based on 10000 runs.BMC Bioinformatics 2008, 9(Suppl 6):S14 http://www.biomedcentral.com/1471-2105/9/S6/S14
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identified overlapping genes using traditional BIUT is
close to the number of nominal false positives (230), sug-
gesting that BIUT lacks power to identify true overlapping
differentially expressed genes. The testing results using
real microarray data confirm our analytical results of The-
orem 1 and Theorem 2 (shown in Methods). In addition
our Monte-Carlo simulation demonstrates that RIUT is a
more powerful and less conservative approach than BIUT.
Detecting genes with time-course and dose-response effect 
to chemical treatment
To further demonstrate the applicability of RIUT in micro-
array studies, we focus on the rat cadmium toxicogenomic
data set [3,18]. This study employed a more complex
study design, in which both gene expression and cytotox-
icity changes were profiled in a multi-dose multi-time-
point setting. Briefly, primary rat hepatocytes were iso-
lated and were exposed to three different doses of cad-
mium acetate (0, 1.25 and 2.0 μM) for 2 h. Cells were
collected at 0, 3, 6, 12 and 24 h in all three groups (0, 1.25
and 2.0 μM Cd) for cytotoxicity evaluation by lactase
dehydrogenase (LDH) leakage as well as for mRNA
expression profiling by DNA microarray. Affymetrix
GeneChip®  oligonucleotide arrays (RatTox U34) were
used for mRNA expression profiling. There are 972 probe
sets representing ~800 important toxicology-related genes
in the RT U34 array. The microarray experiment was
repeated using primary hepatocytes from 3 animals, each
with 2 replicates (independent cultures) for each dosage
(3 dosage levels) at each time point (5 time points),
resulting in a total of 90 chips (3 animals ￿ 2 replicates ￿
3 doses ￿ 5 time points). The 2 replicates were averaged in
our analysis.
Firstly, to identify differentially expressed genes in
responding to cadmium treatment at each time point,
two-sample t-tests were performed between the treatment
(1.25 and 2.0 μM Cd) and control at each time point. Sec-
ondly, to identify the genes with persistent differentially
expression due to cadmium exposure across different time
points, the overlapping of the DEGs at both short term (3
h) and long term (12 h) were identified using our pro-
posed method. The second research question was then
formulated an IUT problem which could be solved using
our proposed method.
We constructed an IUT consisting of two individual tests
(t1: 2.0 μM Cd vs control at 3 h, and t2: 2.0 μM Cd vs con-
trol at 12 h). The joint p-value distribution from t1 and t2
for all genes is illustrated in Figure 2. It is shown that t1
and t2 were approximately independent (R2 = 0.03) and
their p-values were approximately uniformly distributed
under null hypothesis (p1 > 0.05 and p2 > 0.05). Therefore
the assumptions in Theorem 1 and 2 were not violated. In
fact for most microarray-based studies, these assumptions
need to be checked by scatter plot.
Table 4: Number of differentially expressed genes in all drug 
treatment groups
Platforms IUT : A IUT : B IUT : C
RIUT BIUT RIUT BIUT RIUT BIUT
Applied Biosystems 1160 1011 1143
13%
1008 940 763
Agilent 362 262 525 413 452 159
GE Healthcare 697 528 862 723 639 415
Affymetrix (Site 1) 359 251 502 382 422
184%
175
Affymetrix (Site 2) 524 375 724 556 521 289
α = 0.05 (Nominal # false positive < 230)
IUT A: t1: L_AA vs. L_CTL and t2: L_CFY vs. L_CTL
IUT B: t1: L_RDL vs. L_CTL and t2: L_CFY vs. L_CTL
IUT C: t1: L_AA vs. L_CTL and t2: L_RDL vs. L_CTL
Table 2: Monte-Carlo estimates of power (%)
μt2 α = 0.05 α = 0.01
RIUT BIUT RIUT BIUT
0.5 0.057 0.014 0.007 0.001
1.0 0.059 0.029 0.006 0.003
1.5 0.077 0.064 0.008 0.006
2.0 0.085 0.081 0.014 0.012
2.5 0.101 0.101 0.020 0.020
3.0 0.103 0.103 0.023 0.023
3.5 0.109 0.109 0.030 0.030
4.0 0.105 0.105 0.024 0.024
4.5 0.112 0.112 0.027 0.027
5.0 0.104 0.104 0.024 0.024
m = 2, n = 5, and μt1 = 0.5; individual tests were performed at α = 
0.05 or α = 0.01 and each estimate based on 10000 runs.
Table 3: Simulation results of pooled instances
γ K0 K1 RIUT BIUT
V (type 1) S(power) V (type 1) S(power)
0.1 9899 101 482(0.049) 12(0.119) 24(0.002) 1(0.010)
0.2 9607 393 447(0.047) 39(0.099) 32(0.003) 6(0.015)
0.3 9087 913 394(0.043) 98(0.107) 29(0.003) 8(0.009)
0.4 8427 1573 363(0.043) 126(0.080) 33(0.004) 21(0.013)
0.5 7560 2440 310(0.041) 202(0.083) 30(0.004) 28(0.011)
0.6 6470 3530 270(0.042) 264(0.075) 22(0.003) 35(0.010)
0.7 5023 4977 209(0.042) 317(0.064) 23(0.005) 59(0.012)
0.8 3534 6466 119(0.034) 410(0.063) 10(0.003) 83(0.013)
0.9 1893 8107 75(0.040) 483(0.060) 10(0.005) 84(0.010)
m = 2, n = 5, and μt1 = μt2 = 0.5; individual tests were performed at α 
= 0.05 and each estimate were based on 10000 runs.BMC Bioinformatics 2008, 9(Suppl 6):S14 http://www.biomedcentral.com/1471-2105/9/S6/S14
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We performed RIUT and BIUT (m = 2, n = 3) for all 972
probe sets. RIUT identified 80 overlapping probe sets and
traditional BIUT identified 19 at α = 0.05. The power of
IUT methods directly affected the identified gene set on
which the follow-up pathway interpretation was based. To
demonstrate this effect, a pathway enrichment search was
performed by comparing the IUT-identified gene sets with
the specific KEGG pathways [19-21] using a Fisher's Exact
Test on DAVID 2006 [22], resulting in an enrichment p-
value for each pathway which were listed in Table 5. Using
the RIUT gene set, we identified 3 significantly over-
enriched pathways (Fisher Exact p-value < 0.05). How-
ever, using the BIUT gene set, no significant pathways in
KEGG was identified. It has been reported that the metab-
olism of xenobiotics by cytochrome p450 pathway is signifi-
cantly affected by cadmium exposure [23,24]. The activity
of MAPK signaling pathway and porphyrin and chlorophyll
metabolism pathway have also been affected by environ-
mental cadmium exposure [25,26]. Again, Our analysis
results using Cd time-course data set indicate that RIUT is
a more powerful method than BIUT and the significance
can be seen in the biological pathway identification.
Discussion
RIUT can be improved in three ways to be applicable in
more scenarios: (1) estimating unknown nuisance param-
eters; (2) dealing with more than 2 individual tests; and
(3) combining non-independent tests. For the scenario
(1), the current approach for estimating π with an arbi-
trary λ was originally proposed by Storey [14] for estimat-
ing false discovery rate. The authors proposed a bootstrap
method for finding optimal λ which can also be used
here. It should be noted that Theorem 2 is valid no matter
how the λ is chosen and how good π is estimated. For
IUTs consisting of more than 2 individual tests, it is diffi-
cult to obtain the analytical solution as Theorem 1. How-
ever, we can apply a step-up procedure which
agglomeratively applies RIUT on its least significant indi-
vidual test. It is more difficult to extend our procedure for
non-independent tests. It may need a resampling-based
algorithm to incorporating correlation structure of multi-
ple tests and dealing with non-normality issues. Resam-
pling needs intensive computation which can be largely
offset by today's powerful and inexpensive computing
facility. Resampling of IUT is based on resampling of indi-
vidual tests which can be conveniently performed by
either bootstrap or permutation. Bootstrap and permuta-
tion were discussed in many literatures [12,27,28].
Conclusion
Our study demonstrated that the current unadjusted IUT
approaches were overly conservative, which resulted in
loss of power in finding overlapping genes in microarray-
based gene expression studies. Our proposed RIUT was
analytically proved to be a more powerful and less con-
servative approach than the current unadjusted IUT. The
power improvement is more apparent in tests with weak
and moderate effect sizes. This is also demonstrated in
Monte-Carlo simulations and real case studies. In addi-
tion, certain known biologically relevant pathways were
identified using the RIUT-derived overlapping genes
which were not detected by using the traditional BIUT.
Appendix
Let X denote the random vector of data values. Suppose
the probability distribution of X depends on an unknown
parameter  θ. The set of possible values for θ  will be
denoted by Θ. Suppose we have m individual tests and let
Ri denote a rejection region for a level-α test of H0i : θ ∈ Θi
versus HAi : θ ∈ ,  1  ≤ i ≤ m, where Θi is a specified subset
of Θ and   is its complement. Then IUT tests the union
of sets against an intersection of sets.
 versus  ,
with the rejection region  . In other words, the
IUT rejects only if all of the tests reject.
Berger's Theorem: IUT with rejection region R is a level-α
test of H0 versus HA.
Θi
c
Θi
c
H i i
m
00 1 :q ∈=
= ΘΘ ∪ HA
c
i
c
i
m
:q ∈=
= ΘΘ 0 1 ∩
RR i i
m
=
=1 ∩
The joint p-value distribution from t1 and t2 for all genes Figure 2
The joint p-value distribution from t1 and t2 for all 
genes. The IUT consists of two individual two-sample t tests 
(t1: 2.0 μM Cd vs. control at 3 h, t2: 2.0 μM Cd vs. control at 
12 h).BMC Bioinformatics 2008, 9(Suppl 6):S14 http://www.biomedcentral.com/1471-2105/9/S6/S14
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Proof. For any θ ∈ Θ0 and for any 1 ≤ l ≤ m, we have
. Therefore, is IUT is a
level-α test. é
Methods
IUT and UIT
Suppose a gene on which a number of α-level hypothesis
tests were performed, represented as t1, t2,..., tm, where m
is the number of individual tests. Each test ti tests the null
hypothesis H0i versus alternative hypothesis HAi. We can
combine all tests into a Union-Intersection Test (UIT)
which rejects if any of the ti rejects. We can also combine
all tests into an Intersection-Union Test (IUT) which
rejects if all the ti reject. The UIT tests the hypothesis H0 =
{all H0i are true} against HA = {at least one H0i is false}
and the IUT tests the hypothesis H0 = {at least one H0i is
true} against HA = {all H0i are false}. IUT and UIT were
named from the fact that their null and alternative
hypothesis can be described by set intersections and
unions. (see Appendix for details).
The FWER of UIT is defined as α' = Pr(Reject at least one
H0i | all H0i are true). It is well known that in general α' ≠
α. For example, if α = 0.05 and m = 5, α' would be about
0.23 when all individual tests are independent. Therefore
there is a need to adjust α' for IUT and there exist many
procedures to do so, ranging from simple Bonferroni cor-
rection to computer-intensive resampling-based correc-
tion [12,13]. The FWER IUT is α' = Pr(Reject all H0i | at
least one H0i is true). It is also obvious that α' ≠ α for IUT
in general. However unlike the well studied UIT, there is
no known procedure for adjusting the FWER α' for IUT.
The unadjusted IUT, also known as the Berger's approach,
denoted as BIUT, suggests that the overall unadjusted p-
value for IUT is
p = max pi, 1 ≤ i ≤ m,( 1 )
where pi is the p-value for individual tests ti. Berger proved
[10] that the unadjusted IUT is a level-α test if all ti are
level-α tests. Berger's also showed that the above IUT is a
size-α test under certain trivial case such as the case when
exactly one H0i is true while all the other H0i are false.
However, the unadjusted approach is not a size-α test in
general. For example, when considering two independent
individual tests t1 and  t2, the chance of rejecting both
hypotheses is α2 rather than α if both H01 and H02 are true.
Nonetheless, due to its simplicity, the unadjusted IUT
approach was implicitly adopted by current microarray
studies when overlapping genes were taken from several
significant gene lists. This BIUT is equivalent to the Venn
diagram in obtaining overlapping genes from multiple
significant gene lists.
Exact solution for IUT consisting of independent tests
Berger's approach can be very conservative and therefore
substantial power could be lost for detecting overlapping
genes. Given the observed p-values (p1, p2,..., pm) for the m
individual tests, we are interested in estimate p-value for
the entire test H0 of IUT. Here, we define a Westfall-
Young-style p-value [12] for IUT denoted as p',
where Pj denote the distribution for the p-value of the jth
hypothesis under null hypothesis for IUT H0 = {at least
one  H0i is true}. The least significant p-value p  is an
observed statistic and the random variable max Pj is the
test statistic under H0. This definition is intuitive as p-
value measures the probability of false positive under null
hypothesis, where a false positive of IUT means that all
the p-values under H0 are less than the observed p. Similar
to the above equation, we have the following relationship
between the IUT FWER α', and individual test type 1 error
rate α.
α' = Pr(all Pj ≤ α |H0) 1 ≤ i, j ≤ m (3)
Unlike UIT, the null hypothesis H0 of IUT is a composite
hypothesis and contains nuisance parameters. However
under certain conditions, it is possible to derive the ana-
lytical solution for α'. We obtain the following theorems:
Theorem 1
For an IUT constructed from two independent tests t1: H01
vs. HA1, and t2: H02 vs. HA2, both at significance level α,
suppose the observed p-values for t1 and t2 are uniformly
distributed under H01  and  H02  respectively, the exact
FWER α' for the IUT is controlled at
PR P R PR i i
m
l qq q a () ( ) ( ) =≤ ≤
=1 ∩
pP p H
Pp H i j m
j
ji
’P r ( )
Pr max max , ,
=≤
=≤ () ≤≤
all 
,
0
0 1
(2)
Table 5: KEGG pathways Identified and the enrichment p-values
KEGG Pathways Fisher's Exact Test P-Value
Metabolism of xenobiotics by cytochrome P450 0.004
MAPK signaling pathway 0.028
Porphyrin and chlorophyll metabolism 0.030
(Fisher's Exact Test) based on the gene sets derived from RIUT and BIUTBMC Bioinformatics 2008, 9(Suppl 6):S14 http://www.biomedcentral.com/1471-2105/9/S6/S14
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where the true probabilities of alternative hypotheses are
Pr(HA1) = π1 and Pr(HA2) = π2; the type 2 error rate for t1
and t2 are β1 and β2.
Proof:
é
Recall that the p-value is the lowest level of significance at
which the null hypothesis could have been rejected. We
can obtain the adjusted p-value based on the observed p-
values of the individual tests
where p = max(p1, p2).
Theorem 2
The RIUT procedure is universally at least as powerful as
the unadjusted IUT, such that p' ≤ p.
Proof:
é
The above derivation can be visualized in Figure 3, which
shows the partition of outcome space (p1, p2) of the two
independent tests.
The relationship between α' and α is much more compli-
cated in the IUT than that in the UIT. To apply the above
theorem, the nuisance parameters (π1, π2, β1, β2) need to
be estimated. Since there are usually thousands of genes
available for each statistical test, we can obtain crude and
conservative estimates of the parameters according to
[14].
where n is the total number of genes, λ is a chosen fixed
value at 0.25 and pi(j) represents the observed p-value for
the ith test on the jth gene.
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Partition of the sample space of the two dimensional out- come space defined by p1 and p2 Figure 3
Partition of the sample space of the two dimensional 
outcome space defined by p1 and p2. The shaded two 
areas are the true non-null areas for the two individual tests 
respectively. The rejected regions by both tests are high-
lighted in bold rectangles at the four corners of the outcome 
space. Only the lower-left corner is the non-null region from 
both tests and therefore should be rejected by IUT. The 
other three corners are type 1 error region for IUT because 
at least one individual test is making type 1 error.
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